Aşılar, tıbbın insanlığa sağladığı en büyük başarılar arasında olup bugüne kadar milyonlarca kişinin yaşamını kurtarmıştır. Ülkemizde 2017 yılında 23 binden fazla aile aşı reddi talebinde bulunmuştur. Geçmişte salgın hastalıkların yıkıcı etkilerinin pek çok sosyal, coğrafi, ekonomik, kültürel etkilere yol açtığı gözlenmiştir. Bu çalışmada amacımız; COVID-19 pandemisi sırasında Türkiye'de normalleşme sürecinin başlaması sonrasında, geçmişte çocuklarına aşı yaptırmayan ebeveynler ile görüşerek aşı reddi oranlarında bir değişiklik olup olmadığını değerlendirmektir. Gereç ve Yöntemler: Kesitsel tipteki bu araştırmada aşı reddinde bulunan aileler telefon ile aranarak onayları alındıktan sonra anket çalışması gerçekleştirilmiştir. Görüşmeler, ülkemizde "normalleşme sürecinin" başlangıcı olan Haziran 2020 sonrasında gerçekleştirilmiş, ailelerin aşı reddine ilişkin görüşlerinin COVID-19 pandemisinden etkilenip etkilenmediği araştırılmıştır. Bulgular: Aşı reddinde bulunan 82 aile çalışmaya katılmayı kabul etmiş ve anket gerçekleştirilmiştir. Hepatit A aşısı ret oranının (%6,5) diğer aşılara göre yüksek, Hepatit B aşısı ret oranının (%2,1) ise diğer aşılara göre düşük olduğu belirlenmiştir. Aşı reddi için en sık sebep "içeriğine güvenmeme" (%43) olarak gözlenmiştir. Ailelerin tamamı COVID-19 pandemisi kontrol önlemleri kapsamında normalleşme sürecine geçilmesi sonrasında da çocuklarına aşı yaptırmayı düşünmediklerini belirtmiştir. Çocuklarına aşı yaptırmayan ebeveynlere "COVID-19 aşısı olsa kendinize yaptırır mısınız" sorusu sorulduğunda %35,7'si olumlu yanıt vermişlerdir. Sonuç: Çalışmamızda COVID-19 pandemisi için ülkemizde normalleşme sürecine geçilmesi sonrasında ailelerin çocuklarına aşı yaptırma konusunda fikirlerinin değişmediği gözlenmiştir. Aşıların bireysel ve toplumsal faydaları düşünüldüğünde aşı ret oranlarını azaltmaya yönelik çalışmaların önemi ortaya çıkmaktadır.

No abstract

Background The effect of COVID‐19 on smoking behavior is not fully known. Studies evaluating the link between smoking and COVID‐19 have controversial results. This study aims to evaluate patients' smoking status with COVID‐19 and the effect of COVID‐19 on smoking behavior. Methods Data were collected from 150 COVID‐19 patients with a positive polymerase chain reaction test for SARS‐CoV‐2 between 11 March 2020 and 15 May 2020 in Rize, Turkey. Patients were interviewed by phone calls 2 months after their recovery. After 9 months, a follow‐up was performed for those who quit smoking. Results Of the participants, 19 (12.7%) were current smokers before the COVID‐19 diagnosis, and 15 (78.9%) of them stated that they quit smoking after their diagnosis. After nine months of follow‐up, 11 of those 15 participants (57.8%) sustained abstinence. Conclusion Smoking cessation rates are high in people with COVID‐19. Besides, the frequency of sustaining abstinence in the long term was also high in these individuals. The COVID‐19 pandemic should be viewed as an open opportunity to strengthen and prioritize smoking cessation activities.

In our study, it was aimed to examine "antibiotic (AB) prescribed infections" (ABPI) in patients receiving home care service (HCS) in the last year. Patients receiving HCS from a tertiary hospital were evaluated (n=176). In addition to descriptive information such as demographics, devices used and chronic diseases, ABs prescribed to patients in the last year and infections that were the reason for their prescription were screened retrospectively. It was determined that 138 patients had been prescribed AB at least once. In total, 691 ABs were used in 550 prescriptions. It was observed that the most common ABPI was urinary tract infection (44.9%), and the most commonly prescribed AB was amoxicillin-clavulanic acid (n=123). Using assistive devices for breathing and lung disease increased the risk of lower respiratory tract infection, for which ABs were prescribed at least once. These predictive factors were feeding with a nasogastric catheter or percutaneous endoscopic gastrostomy for upper respiratory tract infections and using a urinary catheter for urinary tract infections. Our study revealed the most common ABPI in patients receiving HCS and the factors predicting them. These findings will shed light on the planning and management of HCS.

Aim: In Turkey, family physicians and family health nurses are among the groups fighting COVID-19 on the frontline. This study was aimed to determine depression, anxiety, and sleep disorders and related factor during the COVID-19 pandemic in FPs and FHNs working in Rize. Methods: Single-centered, a cross-sectional web-based survey study was conducted between July 21-31, 2020 in Rize, Turkey. Demographic characteristics and information related to the COVID-19 pandemic were collected from primary health care workers and depression, anxiety, and sleep quality were evaluated by Beck Depression Inventory, Beck Anxiety Inventory, and Pittsburgh Sleep Quality Index, respectively. A total of 109 primary health care workers were included in the study. Results: While 48 (44%) of the primary health care workers had at least mild depressive symptoms, 46 (42.2%) had the least mild anxiety symptoms. Sleep disturbance was also found in 48 (44%) of them. The frequency of psychological symptoms was higher in women, nurses, and those who thought that their protective equipment was insufficient. Sleep disturbances were more common in primary health care workers with psychiatric illness and who suspect they have had COVID-19 at any time. Conclusion: Primary health care workers had a high rate of depression, anxiety, and sleep disorders. It would be beneficial to make special interventions to promote mental health for primary health care workers, who are among the frontline groups in the fight against COVID-19. Keywords: anxiety, COVID-19, depression, health care worker, sleep disorders